Approval · Notice of Compliance 30711 · 2023
MARCAINE E: Notice of Compliance 30711
Issued May 11, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 30711
- Date
- May 11, 2023
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety Updates to the Product Monograph (PM). Migrate PM to 2020 Master Template
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MARCAINE E | Not yet assigned | — |
Medicinal ingredients
- BUPIVACAINE HYDROCHLORIDE 2.5 MG per ML
- EPINEPHRINE BITARTRATE 0.0091 MG per ML
- BUPIVACAINE HYDROCHLORIDE 5 MG per ML